TrialMedical oncology (Northwood, London, England)2013

Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter study.

Ting Deng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.